BioSpace News Archive

Genetown

New Study Says DNA Damage From CRISPR-Cas9 Gene-Editing Has Been Underestimated

Shares of CRISPR Therapeutics (-8 percent), Editas Medicines (-5 percent) and Intellia Therapeutics (-6.7 percent) are all plunging following the release of a report that claimed CRISPR-Cas9 gene editing may cause some dangerous side effects.

July 16, 2018
·
3 min read
·
Alex Keown
Business

Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer of Haploid Stem Cell-Based Diagnostics to Predict Chemotherapy Resistance

Raises $1.925 Million to Support a $2 Million Initial Investment in NewStem Ltd.

July 16, 2018
·
14 min read
NewStem Announces $4 million Seed Investment

Hebrew University Spinout Focuses on Improving Chemotherapy Success

July 16, 2018
·
4 min read
Policy

UTILITY Receives Qualified Infectious Disease Product Designation for Uncomplicated Urinary Tract Infections from US FDA

UTILITY therapeutics Ltd announced that the US Food and Drug Administration (FDA) has designated pivmecillinam as a Qualified Infectious Disease Product (QIDP) for the indication of uncomplicated urinary tract infection (uUTI).

July 16, 2018
·
2 min read
New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery

Masimo announced today the findings of a recently published study in which researchers at Kocaeli University in Turkey compared the performance of conventional fluid management (CFM) to goal-directed fluid management (GDFM) using Masimo PVi®

July 16, 2018
·
7 min read
Business

Marshalls Traditional Healthcare is coming to Amazon.com with its unique Lays skincare product line

Marshalls Traditional Healthcare is coming to Amazon.com with its amazing product line

July 16, 2018
·
2 min read
Business

GB Sciences Partners with the Colorado Hemp Project to Cultivate and Extract Full Spectrum Hemp Oil from Proprietary Hemp Strains to Open a New Revenue Stream in the Rapidly Growing Hemp Market

The first six proprietary strains are being cultivated by The Colorado Hemp Project and will serve as the basis for fresh revenue streams from both retail sales and raw ingredients for cannabis-based medical formulations.

July 16, 2018
·
4 min read
Drug Development

CytoDyn Announces Positive Results from Completed Pivotal PRO 140 HIV Combination Trial

CytoDyn Inc. announces that approximately 81% of patients who completed the 25-week CD02 pivotal trial with PRO 140 in combination with existing highly active antiretroviral therapy (HAART) showed viral load suppression with plasma HIV-1 RNA viral load of less than 50 copies/mL.

July 16, 2018
·
8 min read
Pharm Country

Cognizant Leads the Pack in Life Sciences Digital Services According to New Everest Group Assessment

New PEAK Matrix™ Report Names Cognizant a Leader in Market Share, Vision and Capabilities

July 16, 2018
·
2 min read
Job Trends

DaVita Recognized for Veteran Outreach

Company named 2018 Outstanding Large Employer of the Year by Disabled American Veterans

July 16, 2018
·
2 min read